Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model NEW YORK ( TheStreet) -- Edwards Life (NYSE: EW) hit a new 52-week high Thursday as it is currently trading at $107.28, above its previous 52-week high of $106.94 with 331,255 shares traded as of 12:04 p.m. ET. Average volume has been 904,500 shares over the past 30 days. Edwards Life has a market cap of $12.06 billion and is part of the health care sector and health services industry. Shares are up 47% year to date as of the close of trading on Wednesday. Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. The company has a P/E ratio of 48.9, below the average health services industry P/E ratio of 50.1 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full Edwards Life Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center. FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.